Nirmatrelvir/ritonavir treatment in SARS-CoV-2 positive kidney transplant recipients – a case series with four patients

BACKGROUND: Despite vaccination coronavirus disease 2019 (COVID-19)-associated mortality caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains high in kidney transplant recipients. Nirmatrelvir is a protease inhibitor with activity against SARS-CoV-2. Nirmatrelvir reduces th...

Descripción completa

Detalles Bibliográficos
Autores principales: Schneider, Johanna, Wobser, Rika, Kühn, Wolfgang, Wagner, Dirk, Tanriver, Yakup, Walz, Gerd
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105635/
https://www.ncbi.nlm.nih.gov/pubmed/37061677
http://dx.doi.org/10.1186/s12882-023-03154-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10105635/
https://www.ncbi.nlm.nih.gov/pubmed/37061677
http://dx.doi.org/10.1186/s12882-023-03154-w

Ejemplares similares